<!-- canonical: https://www.trendhunter.com/trends/biosymetrics -->
<!-- robots: noindex -->

# Predictive Patient Outcome Technologies
BioSymetrics Uses Machine Learning to Analyze Patient Data

By Grace Mahas | Published 2020-05-13 | Tech
Source: Trend Hunter, https://www.trendhunter.com/trends/biosymetrics
References: [marsdd](https://www.marsdd.com/magazine/how-canadian-startups-are-tackling-the-covid-19-crisis/?eee) & [biosymetrics](https://www.biosymetrics.com/uniting-against-covid-19/)

The Canadian startup, BioSymetrics, uses [machine learning frameworks](https://www.trendhunter.com/trends/andrew-zhou) coupled with in vivo experimental research (i.e. clinical trials in humans) to [discover new drugs](https://www.trendhunter.com/trends/drug-discovery) and is now using its technology to combat COVID-19. The company's predictive methods are able to [analyze emerging patient data](https://www.trendhunter.com/trends/large-medical-model) to assist healthcare workers to make efficient and effective decisions.

In addition, BioSymetrics is partnering with clinicians to leverage international collaboration in order to de-bias and combine data to determine if any of its early-stage drugs may be effective in combating COVID-19. The company also announced it "will pursue any collaboration to have a positive impact against COVID," inviting brands looking for an AI partner in the global fight against COVID-19 to collaborate.

Image Credit: Shutterstock

## Trend Insights (Trend Hunter)

- Score: 0.5/10
- Popularity: 1% | Activity: 5% | Freshness: 9%
- Audience gender: 50% men, 50% women
- Primary generations: Millennial, Gen X
- Top markets: North America, South America, Europe, Asia, Africa

## Categories

[Trend Hunter](https://www.trendhunter.com/trends) > [Tech](https://www.trendhunter.com/tech) > [AI](https://www.trendhunter.com/ai)

## Key Themes

### What's Driving This Trend

- **Predictive Patient Outcome Technologies:** Using machine learning to analyze patient data to discover new drugs and make efficient and effective decisions.
- **International Collaboration in Clinical Trials:** Partnering with clinicians across the globe to de-bias and combine data.
- **AI Solutions for COVID-19:** Inviting brands to collaborate and pursue any collaboration to have a positive impact against COVID-19.

### Who This Affects Most

- **Pharmaceuticals:** Using predictive patient outcome technologies to discover new drugs.
- **Healthcare:** Implementing machine learning to make efficient and effective decisions for patient care.
- **Technology:** Providing AI solutions for global challenges such as COVID-19.

## Related on Trend Hunter

- [Biology-Focused AI Models](https://www.trendhunter.com/trends/bioptimus.md)
- [AI-Backed Supplement Development](https://www.trendhunter.com/trends/biomdrin.md)
- [AI-Designed Medical Trials](https://www.trendhunter.com/trends/insilico-medicine.md)
- [AI-Enhanced Breast Cancer Treatments](https://www.trendhunter.com/trends/sophia-genetics.md)
- [Prostate Cancer AI Biomarkers](https://www.trendhunter.com/trends/ai-biomarker.md)
- [AI Drug Platforms](https://www.trendhunter.com/trends/insilico-medicine-mmai.md)
- [AI-Driven Imaging Biomarkers](https://www.trendhunter.com/trends/imaging-biomarkers.md)
- [AI-Based Healthcare Technologies](https://www.trendhunter.com/trends/aibased-healthcare.md)
- [AI-Powered Drug Research](https://www.trendhunter.com/trends/xaira-therapeutics.md)
